– Second quarter 2021 Revenue (1) of $312 million , up 20% sequentially and 166% YoY
– Second quarter 2021 Adjusted EBITDA margin of 28% on core U.S. operations, up 400 bps QoQ
– Second quarter 2021 Adjusted EBITDA (1) of $84 million , up 35% sequentially and 201% YoY
– Closed acquisition of EMMAC, Europe’s largest vertically integrated cannabis company
WAKEFIELD, Mass. , Aug. 9, 2021 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”) , a leading international provider of consumer products in cannabis, today reported its financial and operating results for the second quarter ended June 30, 2021 . All financial information is provided in U.S. dollars unless otherwise indicated.
| Second Quarter 2021 Financial Highlights | ||||||||
| ($ thousands, except per share amounts) | Q2 2021 | Q1 2021 | % qoq | Q2 2020 | % yoy | |||
| Total Revenue | $ | 312,205 | $ | 260,320 | 20% | $ | 117,480 | 166% |
| Gross profit before impact of biological assets | $ | 155,238 | $ | 128,467 | 21% | $ | 60,636 | 156% |
| Gross profit on cannabis sales (1)(2) | $ | 154,527 | $ | 128,030 | 21% | $ | 42,735 | 262% |
| Gross margin on cannabis sales (1)(2) | 49.6% | 49.3% | 42.9% | |||||
| Adjusted EBITDA (1) | $ | 84,372 | $ | 62,625 | 35% | $ | 27,994 | 201% |
| Net income (loss) attributable to Curaleaf Holdings Inc. | $... |
|||||||
Read Full Story: https://investingnews.com/daily/cannabis-investing/curaleaf-reports-record-second-quarter-2021-results/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.